Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthma.
AUTHORS
Carroll
KN ,
Gebretsadik
T ,
Escobar
GJ ,
Wu
P ,
Li
SX ,
Walsh
EM ,
Mitchel
E ,
Sloan
CD ,
Dupont
WD ,
Hartert
TV ,
. The Journal of allergy and clinical immunology. 2016 4 21; ().
- PMID: 27212083 [PubMed].
ABSTRACT
Respiratory syncytial virus (RSV) lower respiratory tract infection is implicated in asthma development. RSV immunoprophylaxis during infancy is efficacious in preventing RSV-related hospitalizations and has been associated with decreased wheezing in the first years of life.
Respiratory syncytial virus (RSV) lower respiratory tract infection is implicated in asthma development. RSV immunoprophylaxis during infancy is efficacious in preventing RSV-related hospitalizations and has been associated with decreased wheezing in the first years of life.
Tags: Alumni Publications 2016